These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17137436)

  • 1. Revisiting the metabolic syndrome.
    Chew GT; Gan SK; Watts GF
    Med J Aust; 2006 Oct; 185(8):445-9. PubMed ID: 17137436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of the insulin resistance syndrome.
    Meigs JB
    Curr Diab Rep; 2003 Feb; 3(1):73-9. PubMed ID: 12643149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High cardiometabolic risk in healthy Chilean adolescents: associations with anthropometric, biological and lifestyle factors.
    Burrows R; Correa-Burrows P; Reyes M; Blanco E; Albala C; Gahagan S
    Public Health Nutr; 2016 Feb; 19(3):486-93. PubMed ID: 25990645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the prevalence of the metabolic syndrome improve by applying the International Diabetes Federation criteria?
    Soto González A; Bellido Guerrero D; Buño Soto M; Pértega Díaz S; De Luis D; Lopez de la Torre M; Martínez Olmos M
    Public Health Nutr; 2007 Oct; 10(10A):1173-80. PubMed ID: 17903327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A comparison of the application of two working definitions of metabolic syndrome in Chinese population].
    Jia WP; Xiang KS; Chen L; Lu JX; Bao YQ; Wu YM; Jiang SY
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):534-8. PubMed ID: 15144584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex- and gender-related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome: A review of the literature.
    Pucci G; Alcidi R; Tap L; Battista F; Mattace-Raso F; Schillaci G
    Pharmacol Res; 2017 Jun; 120():34-42. PubMed ID: 28300617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "The metabolic syndrome... is dead": these reports are an exaggeration.
    Tenenbaum A; Fisman EZ
    Cardiovasc Diabetol; 2011 Jan; 10():11. PubMed ID: 21269524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome: demographic features, etiology, and clinical management.
    Wyne KL
    Curr Atheroscler Rep; 2005 Sep; 7(5):381-8. PubMed ID: 16105482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolic syndrome, hyperlipidemia, and insulin resistance.
    Fonseca VA
    Clin Cornerstone; 2005; 7(2-3):61-72. PubMed ID: 16473262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Metabolic Syndrome in Children and Adolescents: Shifting the Focus to Cardiometabolic Risk Factor Clustering.
    Magge SN; Goodman E; Armstrong SC; ; ;
    Pediatrics; 2017 Aug; 140(2):. PubMed ID: 28739653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the relationship between exercise and metabolic abnormalities? A review of the metabolic syndrome.
    Carroll S; Dudfield M
    Sports Med; 2004; 34(6):371-418. PubMed ID: 15157122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of recent definitions of the metabolic syndrome to survey data from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE II).
    Deedwania PC; Maki KC; Dicklin MR; Stone NJ; Ballantyne CM; Davidson MH
    J Cardiometab Syndr; 2006; 1(5):295-300. PubMed ID: 17679790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolic syndrome: diagnosis and treatment.
    Zieve FJ
    Clin Cornerstone; 2004; 6 Suppl 3():S5-13. PubMed ID: 15707265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise training to reduce cardiovascular risk in patients with metabolic syndrome and type 2 diabetes mellitus: How does it work?
    Kränkel N; Bahls M; Van Craenenbroeck EM; Adams V; Serratosa L; Solberg EE; Hansen D; Dörr M; Kemps H
    Eur J Prev Cardiol; 2019 May; 26(7):701-708. PubMed ID: 30317879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of diagnostic criteria for metabolic syndrome to identify insulin resistance].
    Butnoriene J; Norkus A; Bunevicius R; Lasas L
    Medicina (Kaunas); 2006; 42(6):455-63. PubMed ID: 16816539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial.
    Masmiquel L; Leiter LA; Vidal J; Bain S; Petrie J; Franek E; Raz I; Comlekci A; Jacob S; van Gaal L; Baeres FM; Marso SP; Eriksson M;
    Cardiovasc Diabetol; 2016 Feb; 15():29. PubMed ID: 26864124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiometabolic syndrome: pathophysiology and treatment.
    Castro JP; El-Atat FA; McFarlane SI; Aneja A; Sowers JR
    Curr Hypertens Rep; 2003 Oct; 5(5):393-401. PubMed ID: 12948432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolic syndrome in women: a growing problem for cardiac risk.
    Paul S; Smith L
    J Cardiovasc Nurs; 2005; 20(6):427-32. PubMed ID: 16485627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation].
    Vanuzzo D; Pilotto L; Mirolo R; Pirelli S
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):6S-17S. PubMed ID: 18773746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Obesity and Metabolic Syndrome in Children with Type 1 Diabetes: A Comparative Assessment Based on Criteria Established by the International Diabetes Federation, World Health Organisation and National Cholesterol Education Program.
    Yayıcı Köken Ö; Kara C; Can Yılmaz G; Aydın HM
    J Clin Res Pediatr Endocrinol; 2020 Mar; 12(1):55-62. PubMed ID: 31434460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.